Cannabinoid variant: CBDV cannabidivarin

1 Jun 2022 | CBD

 

CBDV is the acronym for cannabidivarin, a natural cannabinoid found in cannabis sativa plants. CBDV was first discovered in 1969 by German researcher L. Vollner. The molecular structure of CBDV is similar to that of CBD (cannabidiol), but it has a propyl chain instead of a pentyl chain. This slight difference classifies CBDV as a propyl cannabinoid, meaning the cannabinoid contains a three-carbon side chain. The molecular structure of CBDV causes slightly different effects than CBD. CBD and CBDV do not cause any psychoactive effects and do not get the user high.

How is CBDV made?

Cannibidivarin is not found in all cannabis plants; CBDV is derived from Indica cannabis landraces containing higher levels of CBD than THC (tetrahydrocannabinol). CBDV is most often extracted from marijuana plants because these plants contain higher levels of CBDV. Landrace means that the cannabis plant was developed in its natural habitat without being crossed with other plants of the same species. These plants usually come from Pakistan, India and Mexico.

Since local cannabis plants are isolated from other cannabis plants to avoid outcrossing, they become a rare plant to find. The legal and political landscape surrounding landrace marijuana has also made it difficult to produce CBDV oil. Hemp-derived CBDV oil is legal in the United States, but it’s hard to find from trusted sources.

What are the benefits of CBDV?

The molecular structure of CBDV allows the cannabinoid to function in the body differently than CBD and other pentyl cannabinoids. The effects of CBDV produce stronger but shorter effects on the human body due to fewer carbon molecules compared to other cannabinoids. Some research has shown that CBDV has the ability to improve bone health and reduce the feeling of nausea.

What is the difference between CBD and CBDV?

As mentioned earlier, the molecular structure between CBD and CBDV is different, which impacts their chemical responses. CBDV can be used to develop THCV (tetrahydrocannabivarin) when exposed to an acidic environment. CBD does not have this same ability to turn into THC.

CBD and CBDV both interact with the endocannabinoid system, but CBDV binds to cannabinoid receptors and CBD simply interacts or blocks the receptors. When CBDV binds to receptors, it allows for faster but shorter results than CBD. The different ways these two interact with the body also elicit different benefits from each other. For example, CBD is known to ease minor discomforts while CBDV can improve bone health. These cannabinoids focus on different health ailments of the body.